SUVEN PHARMACEUTICALS LIMITED |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 804 INR | +2.11% |
|
+11.03% | +11.23% |
| 06-19 | Transcript : Sapala Organics Private Limited, Suven Pharmaceuticals Limited - M&A Call | |
| 06-14 | Suven Pharmaceuticals to Acquire 67.5% Stake in Sapala Organics | MT |
Evolution of the average Target Price on Suven Pharmaceuticals Limited
Price target over the last 5 years
History of analyst recommendation changes
e9dc0f563f74d3a77d5acc5d9.eIF9HoOLD0hhhWUau86f9WvO62GDardS_BR8hC2yIUw.NuQ8fNnFRX9XzzZPw_qmkT6IvRvqJYQrtUEP_Rr_VSIf6SpxsudcfibOFg~86c48a3d04f8b98b3d3440a0d044d2e5
Analysts' Consensus
Sell
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
804
INR
Average target price
670.5
INR
Spread / Average Target
-16.60%
High Price Target
770
INR
Spread / Highest target
-4.23%
Low Price Target
571
INR
Spread / Lowest Target
-28.98%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
D-
EPS Revisions
- Stock Market
- Equities
- SUVENPHAR Stock
- Consensus Suven Pharmaceuticals Limited
